These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18632000)

  • 1. Current and future management of Alzheimer's disease.
    Gauthier S; Poirier J
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S48-50. PubMed ID: 18632000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dementia: is it time for a change in focus?
    Kuller LH; Lopez OL
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S77-84. PubMed ID: 18632006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive stimulation for the treatment of Alzheimer's disease.
    Spector A; Woods B; Orrell M
    Expert Rev Neurother; 2008 May; 8(5):751-7. PubMed ID: 18457532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leon Thal's vision for the treatment and prevention of Alzheimer's disease.
    Weiner MW
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S150-2. PubMed ID: 18631993
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
    Doody RS
    Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke.
    Fillit H; Nash DT; Shineman D
    Alzheimers Dement; 2009 Mar; 5(2):149-53. PubMed ID: 19328448
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
    Gauthier S; Poirier J
    Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447
    [No Abstract]   [Full Text] [Related]  

  • 8. More than a decade of estrogen neuroprotection.
    Simpkins JW; Singh M
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S131-6. PubMed ID: 18631989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular risk factors and Alzheimer's disease].
    Regalado Doña PJ; Azpiazu Artigas P; Sánchez Guerra ML; Almenar Monfort C
    Rev Esp Geriatr Gerontol; 2009; 44(2):98-105. PubMed ID: 19268394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on "a roadmap for the prevention of dementia: the inaugural Leon Thal Symposium." An impending prevention clinical trial for Alzheimer's disease: roadmaps and realities.
    Roses AD
    Alzheimers Dement; 2008 May; 4(3):164-6. PubMed ID: 18631961
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer's and non-alzheimer's dementia: a critical review of pharmacological and nonpharmacological strategies.
    Saddichha S; Pandey V
    Am J Alzheimers Dis Other Demen; 2008; 23(2):150-61. PubMed ID: 18332476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in clinical research on Alzheimer's disease: Leon Thal's legacy.
    Petersen RC
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S88-90. PubMed ID: 18632008
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary on "a roadmap for the prevention of dementia II: Leon Thal symposium 2008." The megacommunity approach to Alzheimer's disease.
    Van Lee R; Meagher B; Fritz P; Penfield S
    Alzheimers Dement; 2009 Mar; 5(2):163-5. PubMed ID: 19328452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of the evaluation criteria used in clinical trials for Alzheimer's disease.
    Truffinet P; Bordet R; Ménard J
    Therapie; 2009; 64(3):139-8. PubMed ID: 19671425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors.
    Snyder PJ; Papp KV; Bartkowiak J; Jackson CE; Doody RS
    Alzheimers Dement; 2009 Mar; 5(2):122-4. PubMed ID: 19328439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.
    Ryan JM; Schneider G; Jacobsen JS
    Alzheimers Dement; 2009 Mar; 5(2):140-2. PubMed ID: 19328445
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Innovations in care that advance Alzheimer's disease drug development.
    Foster NL; Andersen TC; Zamrini EY
    Alzheimers Dement; 2009 Mar; 5(2):159-62. PubMed ID: 19328451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of Alzheimer's disease.
    Souder E; Beck C
    Nurs Clin North Am; 2004 Sep; 39(3):545-59. PubMed ID: 15331301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between atrial fibrillation and other cardiovascular risk factors in Alzheimer's disease. New prevention opportunities].
    Bellomo A; Mancinella M; Troisi G; Marigliano V
    Recenti Prog Med; 2009 Mar; 100(3):124-6. PubMed ID: 19475838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.